CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the 2006 Bear Stearns SMid-Cap Investor Conference on November 15, 2006 at 9:35 a.m. ET at Bear Stearns World Headquarters in New York, NY.
